{"disease":{"id":"first-line-treatment-of-adult-patients-with-locally-advanced-or-metastatic-nsclc-whose-tumors-have-egfr-exon-19-deletions-or-exon-21-l858r-mutations-in-combination-with-pemetrexed-and-platinum-based-chemotherapy.md","name":"first line treatment of adult patients with locally advanced or metastatic nsclc whose tumors have egfr exon 19 deletions or exon 21 l858r mutations in combination with pemetrexed and platinum based chemotherapy.md"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}